Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Strong Economic Data Sparks Sell-Off in S&P 500

Dieter Jaworski by Dieter Jaworski
September 26, 2025
in Analysis, Market Commentary, S&P 500
0
S&P 500 Stock
0
SHARES
100
VIEWS
Share on FacebookShare on Twitter

A batch of unexpectedly robust U.S. economic indicators prompted a wave of selling on Thursday, pulling the S&P 500 down by 0.5%. The benchmark index closed the session at 6,604.72, a decline of 33.25 points, as investors grew concerned that the strong data could delay interest rate cuts from the Federal Reserve.

Market Breadth Signals Widespread Caution

The session marked the third consecutive day of losses for the index, following a series of record highs earlier in the week. The negative sentiment was broad-based, with declining issues outnumbering advancers by a ratio of 3.11 to 1 on the NYSE and 3 to 1 on the Nasdaq. The heightened selling pressure was further evidenced by trading volume, which reached 19.58 billion shares, significantly exceeding the 20-day average.

Selective Gains Amid a Broad Decline

Despite the overall downward trend, several individual stocks posted substantial gains, driven by company-specific news.
* Intel surged as much as 9% amid speculation of a potential investment from Apple.
* IBM advanced over 5% following positive announcements related to its quantum computing collaboration with HSBC.
* Other notable performers included Albemarle (+5.80%), Synopsys (+3.03%), and Charles Schwab (+2.28%).

However, these gains were overshadowed by significant losses elsewhere.
* CarMax plummeted more than 20% after reporting disappointing quarterly results.
* Freeport-McMoRan declined nearly 17%.
* Major technology stocks continued to struggle, with Oracle falling 5.6% and Tesla dropping 4%.

Should investors sell immediately? Or is it worth buying S&P 500?

Technical Support Levels Come Into View

From a technical analysis perspective, the recent upward trend has been challenged. Although the index remains above its 50-day moving average of 6,446, key support levels at 6,611 and 6,506 are now in focus. A sustained break below 6,611 could pave the way for a test of 6,500 and potentially 6,460. While weekly and monthly RSI readings suggest underlying momentum is still intact, the daily Average Directional Index (ADX) indicates the current trend is losing strength—a view supported by the session’s volume analysis.

Macroeconomic Data Fuels Rate Concerns

The primary driver behind the investor retreat was a set of macroeconomic reports that painted a picture of a resilient U.S. economy.
* The second estimate for second-quarter GDP was revised upward to an annualized rate of 3.8%.
* Weekly initial jobless claims unexpectedly fell to 218,000.
* Orders for durable goods showed a recovery.

This strong data has led markets to question the likelihood of imminent Fed easing. In response, the yield on the benchmark 10-year U.S. Treasury note climbed to 4.18%. Simultaneously, the U.S. Dollar Index jumped 0.7% to a three-week high of 98.52, creating an additional headwind for equity valuations.

Attention now turns to Friday’s release of the August Core PCE Price Index, the Federal Reserve’s preferred inflation gauge. Any surprise deviation from forecasts could significantly amplify the current market anxiety surrounding the future path of interest rates.

Ad

S&P 500 Stock: Buy or Sell?! New S&P 500 Analysis from March 25 delivers the answer:

The latest S&P 500 figures speak for themselves: Urgent action needed for S&P 500 investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

S&P 500: Buy or sell? Read more here...

Tags: S&P 500
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Humacyte Stock
Analysis

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026
Evolent Health Stock
AI & Quantum Computing

Evolent Health Bets on AI Leadership Amid Share Price Decline

March 25, 2026
MongoDB Stock
AI & Quantum Computing

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

March 25, 2026
Next Post
Cardiff Oncology Stock

Cardiff Oncology Shares Face Sustained Selling Pressure

Fannie Mae Stock

Political Headwinds Buffet Fannie Mae's Path to Privatization

Unitedhealth Stock

UnitedHealth Navigates Legal Challenges While Pursuing Growth Initiatives

Recommended

iRadimed Stock

iRadimed: Record Performance Meets Divergent Institutional Strategies

7 months ago
Alphabet Stock

Alphabet Shares Under Scrutiny as CEO Pichai Executes Multi-Million Dollar Stock Sale

6 months ago
Bloom Energy Stock

Bloom Energy Shares Plunge Following Spectacular Rally

4 months ago
Strategy Stock

Strategy Shares Plunge Following Dual Capital Raise Announcement

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Hain Celestial Sheds Snack Division in Strategic Overhaul

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

Lumen’s AI Infrastructure Push Gains Recognition Amid Strategic Overhaul

Microsoft’s AI Ambitions Strain Finances as Cash Reserves Shrink

Hesai Group’s Milestone Profit Tempered by Cautious Guidance

Trending

Humacyte Stock
Analysis

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

by SiterGedge
March 25, 2026
0

As Humacyte prepares to release its full-year 2025 financial results, the biotechnology firm finds its stock trading...

Evolent Health Stock

Evolent Health Bets on AI Leadership Amid Share Price Decline

March 25, 2026
MongoDB Stock

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

March 25, 2026
Talphera Stock

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

March 25, 2026
Hain Celestial Stock

Hain Celestial Sheds Snack Division in Strategic Overhaul

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts
  • Evolent Health Bets on AI Leadership Amid Share Price Decline
  • MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com